Add
KOOL to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| KOOL > SEC Filings for KOOL > Form 8-K on 11-Jun-2009 | All Recent SEC Filings |
11-Jun-2009
Change in Directors or Principal Officers, Financial Statements and Exhibits
(d). Appointment of Director On June 8, 2009, the Board of Directors of ThermoGenesis Corp. (the "Company") increased the number of directors on the Company's Board of Directors ("Board") from five to six. Subsequently, the Company's directors elected Mr. J. Melville Engle, the Company's Chief Executive Officer, as a director on the Company's Board. Initially, Mr. Engle will not and is not expected to serve on any committees of the Board.
Prior to joining ThermoGenesis, Mr. Engle, age 59, was Chief Executive Officer
of Raydiance, Inc., a laser technology company. For six years he served as
President and Chief Executive Officer of Dey LP, a $600 million specialty
pharmaceutical company, an affiliate of Merck KGaA. While at Dey, he served as
Regional Director, North America, for the Merck Generics Group. He also served
as Chairman, President and Chief Executive Officer of Anika Therapeutics, Inc.,
a publicly traded medical device company, and held senior financial, operations
and sales positions at Allergan, Inc. Engle is currently a member of the board
of directors of Oxygen Biotherapeutics (OXBO), a company developing
pharmaceuticals and medical devices in the field of oxygen therapeutics and
continuous substrate monitoring.
Engle holds a B.S. in Accounting from the University of Colorado and an M.B.A.
in Finance from the University of Southern California.
There have been no related party transactions between Mr. Engle and the Company. During the last fiscal year Mr. Engle has not been a party to any transaction or proposed transaction, to which the Company is or was to be a party, in which Mr. Engle would have a direct or indirect material interest. Mr. Engle has no family relationships with any director or executive officer of the Company, or persons nominated or chosen by the Company to become directors or executive officers.
For more information, see the press release attached as Exhibit 99.1.
99.1 Press release dated June 10, 2009, titled "ThermoGenesis Appoints Chief Executive Officer J. Melville ("Mel") Engle to Board of Directors"
|
|